Viemed Healthcare (VMD) Net Income towards Common Stockholders (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Viemed Healthcare | 373.53 Mn | 365.70 Mn | 42.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.35% |
| Dec 31, 2025 | 61.56% |
| Sep 30, 2025 | 10.77% |
| Jun 30, 2025 | 19.93% |
| Mar 31, 2025 | -38.74% |
| Dec 31, 2024 | 13.29% |
| Sep 30, 2024 | 164.39% |
| Jun 30, 2024 | -7.86% |
| Mar 31, 2024 | -53.90% |
| Dec 31, 2023 | 19.12% |
| Sep 30, 2023 | 25.28% |
| Jun 30, 2023 | 53.59% |
| Mar 31, 2023 | -37.78% |
| Dec 31, 2022 | 131.09% |
| Sep 30, 2022 | 9.10% |
| Jun 30, 2022 | -45.12% |
| Mar 31, 2022 | -56.89% |
| Dec 31, 2021 | 128.45% |
| Sep 30, 2021 | 14.24% |
| Jun 30, 2021 | -7.01% |
| Mar 31, 2021 | -66.79% |
| Dec 31, 2020 | 80.85% |
| Sep 30, 2020 | -85.56% |
| Jun 30, 2020 | 357.51% |
| Mar 31, 2020 | 77.68% |
| Dec 31, 2019 | -16.30% |
| Sep 30, 2019 | 115.16% |
| Jun 30, 2019 | -32.28% |
| Mar 31, 2019 | -34.03% |
| Dec 31, 2018 | 33.75% |
| Sep 30, 2018 | 5.77% |
| Jun 30, 2018 | -5.62% |